Start adding items to your reading lists:or
Save this item to:
This item has been saved to your reading list.
How will you position yourself to emerge stronger?
PwC’s HRI projects that medical cost trend could range from 4% to 10%
PwC’s Health Research Institute examines the top health industry issues of 2021 including virtual health, clinical trial disruption, M&A, resilient supply chains and interoperability.
In this current environment of uncertainty, the health industry is being fundamentally challenged: our traditional business models, financial performance and the ways we work. In this unprecedented time, health organizations are uncovering new value and accelerating the velocity of their innovations to emerge stronger.
We are focused in a range of areas including: strategy, operations, technology, finance, people and change, risk and forensics.
We have a deep industry experience helping address major challenges in R&D, supply chain and sales and marketing. We work across a range of corporate functions, including regulatory compliance, IT, finance, human resources and business development, strategic transformation, clinical transformation, revenue cycle, operations and M&A strategy. Learn more.
We are a market leader in providing accounting and auditing services in the healthcare, pharmaceutical and life sciences industries. We work with the some of the largest global organizations in these industries as well as emerging and early stage companies, helping them prepare for and meet the requirements for accessing the public market as well as obtaining private equity or venture funding. Our aim is to deliver services that support your ability to provide corporate stakeholders with accurate and understandable financial and operational information about your business. Learn more.
We deliver highly focused, practical tax ideas and solutions. Our tax specialists provide the full spectrum of support from tax structuring and strategy through to compliance services (including co-sourcing and outsourcing).
We understand the industry and how tax concerns impact a wide range of areas such as R&D credits, transfer pricing, intellectual property management, treasury strategies, mergers, acquisitions and divestitures, Form 990 reporting, state and local planning and expansion of global programs. Learn more.
US Health Industries Leader, PwC US
US Health Industries Advisory Leader, PwC US
US Health Services Leader, PwC US
US Pharmaceutical and Life Sciences Leader, PwC US